Emergence of an epidemic hypervirulent clone of Enterobacter hormaechei coproducing mcr-9 and carbapenemases

生物 阴沟肠杆菌 微生物学 仆从 肠杆菌 人口 病毒学 肠杆菌科 医学 纳米孔测序 遗传学 DNA测序 基因 大肠杆菌 DNA 环境卫生
作者
Tingting Xu,Chun‐Xu Xue,Junxi Huang,Jingsong Wu,Rongchang Chen,Kai Zhou
出处
期刊:The Lancet microbe [Elsevier BV]
卷期号:3 (7): e474-e475 被引量:21
标识
DOI:10.1016/s2666-5247(22)00122-7
摘要

Enterobacter cloacae complex (ECC) is an important nosocomial pathogen encompassing at least 22 species. Some of the species, such as E hormaechei and E asburiae, are clinically prevalent and frequently associated with a multidrug resistance phenotype.1Zhou K Yu W Cao X et al.Characterization of the population structure, drug resistance mechanisms and plasmids of the community-associated Enterobacter cloacae complex in China.J Antimicrob Chemoth. 2018; 73: 66-76Crossref PubMed Scopus (20) Google Scholar ECC is conventionally considered a low-virulence pathogen and often causes infections in immunocompromised patients, although interspecies diversities of pathogenicity have been noted in studies.2Davin-Regli A Lavigne J-P Pagès J-M Enterobacter spp: update on taxonomy, clinical aspects, and emerging antimicrobial resistance.Clin Microbiol Rev. 2019; 32: e00002-e00019Crossref PubMed Scopus (108) Google Scholar A 2021 cohort study uncovered a hypervirulent species of ECC, E bugandensis, which was responsible for fatal septic shocks of newborn babies in a neonatal intensive care unit in France.3Girlich D Ouzani S Emeraud C et al.Uncovering the novel Enterobacter cloacae complex species responsible for septic shock deaths in newborns: a cohort study.Lancet Microbe. 2021; 2: e536-e544Summary Full Text Full Text PDF PubMed Scopus (2) Google Scholar The pathogenicity of the E bugandensis isolates was higher than that of strains from other species evaluated with a Galleria mellonella infection model. In this Comment we report an epidemic hypervirulent clone of E hormaechei showing high invasiveness in a clinical setting. We collected 230 non-repetitive clinical ECC isolates at a tertiary hospital between 2000 and 2018, and two mcr variants (mcr-9 and mcr-10) were detected in 48 of those isolates by PCR screening. 18 sequence types and seven novel sequence trypes were identified in the mcr-producing isolates (MCR-ECC), and ST133 was predominant (20·8%; 10/48), followed by ST418 (8·3%; 4/48), then ST56 (8·3%; 4/48). ST133 and ST418 belong to E hormaechei, and ST56 belongs to E kobei. Multiple carbapenemase genes (12 blaNDM-1, eight blaIMP-4, and one blaIMP-26) were found in 16 of the 48 MCR-ECC isolates, and eight belong to ST133. The ten ST133 isolates were multidrug-resistant, of which eight carbapenemase-producing isolates were resistant to meropenem and imipenem. However, nine isolates showed susceptibility to polymyxin B and colistin (table). 85 ST133 isolates were detected in 3601 ECC genomes retrieved from the National Center for Biotechnology Information (NCBI) Reference Sequence database on October 1, 2021. These isolates were obtained from at least ten countries across five continents, suggestive of an epidemic clone. Of these isolates, 35 (41·2%) harboured mcr-9 and 11 (12·9%) had carbapenemase genes as well as mcr-9 (appendix 1). Four observational studies have reported that ST133 was an endemic carbapenem-resistant clone in multiple countries.4Kananizadeh P Oshiro S Watanabe S et al.Emergence of carbapenem-resistant and colistin-susceptible Enterobacter cloacae complex co-harboring blaIMP-1 and mcr-9 in Japan.BMC Infect Dis. 2020; 20: 282Crossref PubMed Scopus (17) Google Scholar, 5Guillard T Cholley P Limelette A et al.Fluoroquinolone resistance mechanisms and population structure of Enterobacter cloacae non-susceptible to ertapenem in north-eastern France.Front Microbiol. 2015; 61186Crossref PubMed Scopus (21) Google Scholar, 6Kraftova L Finianos M Studentova V et al.Evidence of an epidemic spread of KPC-producing Enterobacterales in Czech hospitals.Sci Rep. 2021; 1115732Crossref PubMed Scopus (3) Google Scholar, 7Sidjabat HE Townell N Nimmo GR et al.Dominance of IMP-4-producing Enterobacter cloacae among carbapenemase-producing Enterobacteriaceae in Australia.Antimicrob Agents Chemother. 2015; 59: 4059-4066Crossref PubMed Scopus (54) Google Scholar The data suggest that coexistence of mcr-9 and carbapenemase genes was prevalent in ST133. Phylogenetic reconstruction of the 85 ST133 genomes with the ten ST133 genomes obtained in this study suggested that the clone has split into two clades, and our isolates were assigned to one clade alongside those isolates from the UK, USA, Germany, Czech Republic, and South Africa (appendix 1).TableInformation of the ten ST133 isolatesYear of isolateSpecimenAge, yearsGenderMinimum inhibitory concentration (mg/L)mcrCarbapenemase genesCAZCXMFEPIPMMEMCIPAMPGENCSLSXTCHLPMBCSTTGCECC452015Catheter83Female>64*Resistant to the drug.>64*Resistant to the drug.>64*Resistant to the drug.4*Resistant to the drug.4*Resistant to the drug.1*Resistant to the drug.>128*Resistant to the drug.128*Resistant to the drug.>128*Resistant to the drug.>320*Resistant to the drug.>128*Resistant to the drug.224*Resistant to the drug.mcr-9.1blaNDM-1, blaIMP-4ECC462015Urine60Female>64*Resistant to the drug.>64*Resistant to the drug.64*Resistant to the drug.4*Resistant to the drug.4*Resistant to the drug.1*Resistant to the drug.>128*Resistant to the drug.128*Resistant to the drug.128*Resistant to the drug.>320*Resistant to the drug.>128*Resistant to the drug.228*Resistant to the drug.mcr-9.1blaNDM-1, blaIMP-4ECC472016Urine74Female>64*Resistant to the drug.>64*Resistant to the drug.>64*Resistant to the drug.16*Resistant to the drug.16*Resistant to the drug.1*Resistant to the drug.>128*Resistant to the drug.128*Resistant to the drug.>128*Resistant to the drug.>320*Resistant to the drug.>128*Resistant to the drug.222*Resistant to the drug.mcr-9.1blaNDM-1, blaIMP-4ECC482016Abdominal fluid65Male>64*Resistant to the drug.>64*Resistant to the drug.64*Resistant to the drug.4*Resistant to the drug.8*Resistant to the drug.1*Resistant to the drug.>128*Resistant to the drug.128*Resistant to the drug.>128*Resistant to the drug.>320*Resistant to the drug.>128*Resistant to the drug.220·5*Resistant to the drug.mcr-9.1blaNDM-1, blaIMP-4ECC522016Cerebrospinal fluid43Male>64*Resistant to the drug.>64*Resistant to the drug.16*Resistant to the drug.4*Resistant to the drug.4*Resistant to the drug.1*Resistant to the drug.>128*Resistant to the drug.>128*Resistant to the drug.>128*Resistant to the drug.>320*Resistant to the drug.>128*Resistant to the drug.220·5*Resistant to the drug.mcr-9.1blaIMP-4ECC542016Drainage39Male>64*Resistant to the drug.>64*Resistant to the drug.64*Resistant to the drug.2*Resistant to the drug.4*Resistant to the drug.2*Resistant to the drug.>128*Resistant to the drug.>128*Resistant to the drug.>128*Resistant to the drug.>320*Resistant to the drug.>128*Resistant to the drug.220·5mcr-9.1blaIMP-4ECC1472005Pancreas40Male64*Resistant to the drug.>64*Resistant to the drug.20·25<0·06251*Resistant to the drug.>128*Resistant to the drug.128*Resistant to the drug.4>320*Resistant to the drug.>128*Resistant to the drug.24*Resistant to the drug.1*Resistant to the drug.mcr-9.1..ECC1882015Blood40Male>64*Resistant to the drug.>64*Resistant to the drug.>64*Resistant to the drug.4*Resistant to the drug.12*Resistant to the drug.>128*Resistant to the drug.>128*Resistant to the drug.>128*Resistant to the drug.>320*Resistant to the drug.>128*Resistant to the drug.0·250·50·5*Resistant to the drug.mcr-9.1blaIMP-4ECC1892015Urine60Female>64*Resistant to the drug.>64*Resistant to the drug.>64*Resistant to the drug.32*Resistant to the drug.4*Resistant to the drug.>16*Resistant to the drug.>128*Resistant to the drug.>128*Resistant to the drug.>128*Resistant to the drug.>320*Resistant to the drug.>128*Resistant to the drug.>32*Resistant to the drug.0·58*Resistant to the drug.mcr-9.1blaNDM-1, blaIMP-4ECC1932016Catheter67Male>64*Resistant to the drug.>64*Resistant to the drug.16*Resistant to the drug.111*Resistant to the drug.>128*Resistant to the drug.128*Resistant to the drug.>128*Resistant to the drug.>320*Resistant to the drug.>128*Resistant to the drug.220·5*Resistant to the drug.mcr-9.1..CAZ=ceftazidime. CXM=cefuroxime. FEP=cefepime. IPM=imipenem. MEM=meropenem. CIP=ciprofloxacin. AMP=ampicillin. GEN=gentamicin. CSL=cefoperazone. SXT=sulfamethoxazole. CHL=chloramphenicol. PMB=polymyxin B. CST=colistin. TGC=tigecycline.* Resistant to the drug. Open table in a new tab CAZ=ceftazidime. CXM=cefuroxime. FEP=cefepime. IPM=imipenem. MEM=meropenem. CIP=ciprofloxacin. AMP=ampicillin. GEN=gentamicin. CSL=cefoperazone. SXT=sulfamethoxazole. CHL=chloramphenicol. PMB=polymyxin B. CST=colistin. TGC=tigecycline. Eight of the ten ST133 isolates were obtained from sterile-site specimens of patients (table), suggestive of an invasive clone. Among the patients positive for ST133, six were men and six were aged 60 years or older. All patients had underlying diseases and received antimicrobial therapy, except for one patient for whom data could not be recovered. A high mortality (40%) was found; four patients died and five patients were discharged. 36 (76·6%) of the 85 ST133 genomes with source information retrieved from NCBI were obtained from sterile-site specimens (appendix 2). In particular, 24 of 39 ST133 isolates in the UK were obtained from blood samples (13 isolates were obtained without source information). Additionally, an outbreak of NDM-1 producing ST133 was reported in a surgical intensive care unit in Croatia, and two of four infected patients died as a result of severe intra-abdominal infections caused by the clone.8Petrosillo N Vranic-Ladavac M Feudi C et al.Spread of Enterobacter cloacae carrying blaNDM-1, blaCTX-M-15, blaSHV-12 and plasmid-mediated quinolone resistance genes in a surgical intensive care unit in Croatia.J Glob Antimicrob Resist. 2016; 4: 44-48Crossref PubMed Scopus (11) Google Scholar Due to the high mortality and invasiveness of ST133, we propose that it could be hypervirulent. The virulence of the ten ST133 isolates collected in this study was further tested with a G mellonella larvae infection model. After being infected for 24 h at an inoculum of 5 × 106 colony forming unit, survival rates of G mellonella were 30% or less for all ST133 isolates (especially 0% for two of them). A survival rate of 0% was recorded for the hypervirulence control strain Klebsiella pneumoniae ATCC43816 (K2 serotype), and a survival rate of 95·8% was recorded for the hypovirulence control strain E cloacae ATCC13047 (appendix 1). These data show that the ST133 clone was hypervirulent. Although multiple epidemic carbapenem-resistant clones of ECC (eg, ST114, ST171, and ST78) have been reported, to our knowledge ST133 is the first carbapenem-resistant hypervirulent clone of ECC frequently causing invasive infections worldwide. The convergence of resistance to last-resort antibiotics and hypervirulence in the species of ECC with clinical significance (ie, E hormaechei) would exacerbate clinical outcomes. We declare no competing interests. This work was supported by the National Key R&D Program of China (2021YFC2300300 and 2022YFE0103200), National Natural Science Foundation of China (82172330 and 81902030), Shenzhen Basic Research Key Project (JCYJ20200109144220704), and Shenzhen Basic Research Project (JCYJ20190807144409307 and JCYJ20210324113608022). The genome sequences have been deposited into GenBank under the bioprojects PRJNA752244 and PRJNA750885. Download .pdf (.72 MB) Help with pdf files Supplementary appendix 1 Download .pdf (.2 MB) Help with pdf files Supplementary appendix 2
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
crist发布了新的文献求助10
刚刚
li完成签到,获得积分10
刚刚
闪闪映天发布了新的文献求助10
1秒前
Z奋勇完成签到 ,获得积分10
1秒前
soile发布了新的文献求助10
1秒前
俏皮的姣完成签到,获得积分10
1秒前
1秒前
英俊的铭的应助被开心德地采纳,获得10
3秒前
4秒前
alex的应助被LJH采纳,获得10
4秒前
Yan发布了新的文献求助10
5秒前
6秒前
JJ呦发布了新的文献求助20
6秒前
风为裳完成签到,获得积分10
7秒前
爆米花的应助被十一苗采纳,获得10
7秒前
7秒前
9秒前
9秒前
乌冬面完成签到,获得积分10
10秒前
10秒前
11秒前
Ava的应助被开心德地采纳,获得10
11秒前
12秒前
Lm完成签到,获得积分20
12秒前
13秒前
epsilon发布了新的文献求助10
13秒前
闫雨发布了新的文献求助10
14秒前
秋风的应助被nono采纳,获得10
14秒前
14秒前
秦奥洋完成签到,获得积分10
14秒前
ikouyo发布了新的文献求助10
14秒前
qwer发布了新的文献求助10
15秒前
也未可知发布了新的文献求助10
15秒前
JamesPei的应助被周小鱼采纳,获得10
15秒前
15秒前
hy发布了新的文献求助10
17秒前
繁花完成签到,获得积分10
17秒前
小赵完成签到,获得积分10
17秒前
18秒前
222发布了新的文献求助10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188916
求助须知:如何正确求助?哪些是违规求助? 9576493
关于积分的说明 21848018
捐赠科研通 7786982
什么是DOI,文献DOI怎么找? 3435461
关于科研通互助平台的介绍 2559689
邀请新用户注册赠送积分活动 2482383